A131 OUTCOMES AND COMPLICATIONS OF THERAPEUTIC ERCP IN DIFFERENT AGE GROUPS
E Hazan, C Na, A Zarrin, A Mokhtar, K Khalaf, N Gimpaya, M Meleka, D Tham, S P Abal, W Mhalawi, D Chopra, S Gupta, S Jugnundan, N Calo, C Teshima, J Mosko, G May, S Grover

TL;DR
This study examines how age affects the success and safety of ERCP procedures, finding that while ERCP remains safe, success rates decrease and procedure times increase in older patients.
Contribution
The study provides evidence on the impact of age on ERCP outcomes, particularly in elderly patients.
Findings
ERCP success rates decline with increasing age, from 91.3% in patients under 40 to 84.9% in those over 80.
Procedure duration increases significantly in older age groups, but complication rates remain consistent across all age groups.
Abstract
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a vital procedure for hepatobiliary disease management. Though it boasts high overall success rates, the impact of patient age on outcomes remains uncertain, especially amongst elderly patients. With an aging population, it is crucial to determine the efficacy and safety of ERCP in different age groups. This study assesses ERCP success and complication rates across age groups. Our objective is to investigate whether ERCP remains a reliable and safe procedure for patients of all ages, particularly the elderly. A database with retrospective data from consecutive patients undergoing ERCP at a Canadian tertiary care centre between 2011 and 2020 was utilized. Baseline patient characteristics and indications for ERCP were collected. Outcomes included procedural success, complications, and procedure duration. Patients were categorized…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmunodeficiency and Autoimmune Disorders · Chronic Lymphocytic Leukemia Research · Autoimmune Bullous Skin Diseases
